Announcements and Notices - [Other - Miscellaneous / Revision of Published Financial Statements and Reports]

Tianjin TEDA Biomedical Engineering Company Limited researches, develops, markets, and sells biomedical equipment, biomaterials, and diabetic health products.

Supplemental Announcement In
Relation To The 2019 Annual Report

Announcements and Notices - [Other - Miscellaneous]

Voluntary Announcement
Appointment Of Chief Advisor

The Articles Of Association

Financial Statements/ESG Information - [Interim/Half-Year Report]

Interim Report 2025

Announcements and Notices - [Results of EGM/SGM]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Tianjin Teda Biomedical H (8189 HK)

Supplemental Announcement In Relation To The 2019 Annual Report

Voluntary Announcement Appointment Of Chief Advisor

The Articles Of Association

Interim Report 2025

Poll Results Of Extraordinary General Meeting

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)